Kairos Pharma (KAPA) Stock Price, Quote, News & History

Comments

Kairos Pharma Ltd (KAPA) Stock Price, Quote, News & History

KAPAAMEX

Trade with Public

$0.5949

-0.0073-1.21%

Last update: Mar 26, 3:07 PM

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.60

Close

-

Volume / Avg.

44.48K / 536.05K

Day Range

$0.57 - $0.60

52 Wk Range

0.40 - 2.11

Market Cap

$12.39M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

45

Short Interest

1.41%

Days to Cover

1

Recent Kairos Pharma Ltd News

Why Is Kairos Pharma Stock Surging On Tuesday?

Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the first 10 patients.

Vandana Singh

Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.16M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

6.52M

Free Cash Flow (TTM)

-4.16M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

2.36M

Analyst Trends and Forecast

2

Oct 25

2

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.46M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.64

Earnings Yield % (TTM)

-51.48%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.37

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$5.58M

Debt to Equity

-

Issuance of Debt (TTM)

-$142.00K

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.60

Close

-

Volume / Avg.

44.48K / 536.05K

Day Range

$0.57 - $0.60

52 Wk Range

0.40 - 2.11

Market Cap

$12.39M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

45

Short Interest

1.41%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small mo...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kairos Pharma (KAPA) stock?

A

You can purchase shares of Kairos Pharma (AMEX:KAPA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kairos Pharma (KAPA) competitors?

A

Other companies in Kairos Pharma’s space includes: Outlook Therapeutics Inc (NASDAQ:OTLK), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX), Intensity Therapeutics Inc (NASDAQ:INTS) and Cellectar Biosciences Inc (NASDAQ:CLRB).

Q

What is the forecast, or price target, for Kairos Pharma (KAPA) stock?

A

Kairos Pharma has a consensus price target of $8.50.

Q

What is the current price for Kairos Pharma (KAPA)?

A

The stock price for Kairos Pharma (AMEX: KAPA) is $0.5949 last updated March 26, 2026 at 3:07 PM EDT.

Q

Does Kairos Pharma (KAPA) pay a dividend?

A

There are no upcoming dividends for Kairos Pharma.

Q

When is Kairos Pharma (AMEX:KAPA) reporting earnings?

A

Kairos Pharma does not have any upcoming earnings scheduled.

Q

Is Kairos Pharma (KAPA) going to split?

A

There is no upcoming split for Kairos Pharma.

Q

What sector and industry does Kairos Pharma (KAPA) operate in?

A

Kairos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch

Outlook Therapeutics Inc

NASDAQ:OTLK

$0.22

5.87%

Acurx Pharmaceuticals Inc

NASDAQ:ACXP

$4.05

-5.15%

Quoin Pharmaceuticals Ltd

NASDAQ:QNRX

$7.41

-20.06%

Intensity Therapeutics Inc

NASDAQ:INTS

$6.01

-5.80%

Cellectar Biosciences Inc

CollPlant Biotechnologies Ltd

NASDAQ:CLGN

$0.83

10.64%

Key Statistics

Open

$0.60

Close

-

Volume / Avg.

44.48K / 536.05K

Day Range

$0.57 - $0.60

52 Wk Range

0.40 - 2.11

Market Cap

$12.39M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

45

Short Interest

1.41%

Days to Cover

1

Recent Kairos Pharma Ltd News

Why Is Kairos Pharma Stock Surging On Tuesday?

Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the first 10 patients.

Vandana Singh

Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.16M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

6.52M

Free Cash Flow (TTM)

-4.16M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

2.36M

Analyst Trends and Forecast

2

Oct 25

2

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.46M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.64

Earnings Yield % (TTM)

-51.48%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.37

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$5.58M

Debt to Equity

-

Issuance of Debt (TTM)

-$142.00K

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.60

Close

-

Volume / Avg.

44.48K / 536.05K

Day Range

$0.57 - $0.60

52 Wk Range

0.40 - 2.11

Market Cap

$12.39M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

45

Short Interest

1.41%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small mo...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry